Wintrust Investments’s Novartis NVS Stock Holding History

Wintrust Investments’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,700	Closed	-$236K	–	429
2021 Q4	$236K	Buy	2,700 +78	+3%	+$6.48K	0.02%	379
2021 Q3	$214K	Sell	2,622 -150	-5%	-$13.5K	0.03%	258
2021 Q2	$253K	Buy	2,772 +158	+6%	+$14.1K	0.03%	371
2021 Q1	$223K	Sell	2,614 -4	-0.2%	-$359	0.02%	375
2020 Q4	$247K	Sell	2,618 -19	-0.7%	-$1.66K	0.07%	155
2020 Q3	$229K	Sell	2,637 -109	-4%	-$9.44K	0.03%	306
2020 Q2	$240K	Sell	2,746 -94	-3%	-$8.11K	0.03%	301
2020 Q1	$234K	Sell	2,840 -394	-12%	-$35.2K	0.04%	278
2019 Q4	$306K	Sell	3,234 -8	-0.2%	-$718	0.04%	288
2019 Q3	$282K	Sell	3,242 -372	-10%	-$33.4K	0.04%	294
2019 Q2	$330K	Sell	3,614 -3,439	-49%	-$291K	0.05%	272
2019 Q1	$608K	Buy	7,053 +451	+7%	+$36.2K	0.1%	172
2018 Q4	$508K	Buy	6,602 +25	+0.4%	+$1.95K	0.1%	180
2018 Q3	$508K	Sell	6,577 -591	-8%	-$43.7K	0.08%	214
2018 Q2	$485K	Buy	7,168 +3,374	+89%	+$233K	0.08%	216
2018 Q1	$275K	Buy	3,794 +14	+0.4%	+$1.07K	0.07%	209
2017 Q4	$284K	Sell	3,780 -105	-3%	-$7.92K	0.07%	231
2017 Q3	$299K	Hold	3,885	–	–	0.08%	224
2017 Q2	$291K	Buy	3,885 +194	+5%	+$13.8K	0.08%	234
2017 Q1	$246K	Buy	+3,691	New	+$246K	0.07%	256
2016 Q4	–	Sell	-4,081	Closed	-$289K	–	238
2016 Q3	$289K	Sell	4,081 -565	-12%	-$41.2K	0.13%	144
2016 Q2	$43K	Buy	+4,646	New	+$321K	0.08%	107

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wintrust Investments's NVS Position: Q1 2022 in Review

Wintrust Investments sold out of Novartis (NVS) in Q1 2022, closing a stake of 2,700 shares — an estimated $236K sold.

Wintrust Investments first reported a position in NVS in Q2 2016 and held it in 22 quarters. The position peaked at $608K in Q1 2019. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2022.

Wintrust Investments reported no remaining Novartis position as of Q1 2022 after selling out during the quarter.
Wintrust Investments sold 2,700 Novartis shares in Q1 2022, an estimated $236K.
Wintrust Investments first reported a position in Novartis in Q2 2016 and held it in 22 quarters.
Wintrust Investments's Novartis position peaked at $608K in Q1 2019.
1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2022.

Based on Wintrust Investments's 13F filing for Q1 2022, filed 11 May 2022.